Michael Brian Bell Guardant Health, Inc. (GH) insider trading activity

Michael Brian Bell is Chief Financial Officer of Guardant Health, Inc.. Currently has a direct ownership of 43,028 shares of GH, which is worth approximately $2.2 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 1,233 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43K

6.54% 3M change

133.68% 12M change

Total Value Held $2.2 Million

Michael Brian Bell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2024	BUY Exercise of conversion of derivative security	-	1,233 Added 8.74%	12,882 Common Stock
Jan 15 2024	SELL Payment of exercise price or tax liability	$32,815 $24.2 p/Share	1,356 Reduced 10.43%	11,649 Common Stock
Jan 15 2024	BUY Exercise of conversion of derivative security	-	3,308 Added 20.28%	13,005 Common Stock
Dec 15 2023	SELL Payment of exercise price or tax liability	$12,037 $28.19 p/Share	427 Reduced 4.22%	9,697 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	-	1,233 Added 10.86%	10,124 Common Stock
Sep 15 2023	SELL Payment of exercise price or tax liability	$12,609 $29.53 p/Share	427 Reduced 4.58%	8,891 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	-	1,233 Added 11.69%	9,318 Common Stock
Jun 15 2023	SELL Payment of exercise price or tax liability	$16,166 $37.86 p/Share	427 Reduced 5.02%	8,085 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	-	1,233 Added 12.65%	8,512 Common Stock
Mar 15 2023	SELL Payment of exercise price or tax liability	$45,606 $26.78 p/Share	1,703 Reduced 18.96%	7,279 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	-	4,931 Added 35.44%	8,982 Common Stock
Jan 15 2023	SELL Payment of exercise price or tax liability	$40,167 $30.43 p/Share	1,320 Reduced 24.58%	4,051 Common Stock
Jan 15 2023	BUY Exercise of conversion of derivative security	-	3,309 Added 38.12%	5,371 Common Stock
Jan 15 2022	SELL Payment of exercise price or tax liability	$96,665 $77.58 p/Share	1,246 Reduced 37.67%	2,062 Common Stock
Jan 15 2022	BUY Grant, award, or other acquisition	-	3,308 Added 50.0%	3,308 Common Stock

Also insider at

CDNA

CareDx, Inc. Healthcare

Chief Financial Officer

MBB